For every dollar they must spend on compliance, that is money being taken away from research and development.

I want to thank Congressman Fitzpatrick for introducing the Fostering Innovation Act to continue this important exemption for smaller issuers.

I would also encourage the subcommittee to consider a small issuer exemption for XBRL reporting, which is a drain on both financial and personnel resources for growing businesses.

Spending investment dollars on compliance can limit R&D and delay R&D so changes like the on-ramp, Congressman Fitzpatrick's legislation, and Congressman Hurt's audit firm rotation bill are important for growing biotechs without product…

Congress now has the opportunity to ensure a positive trading environment for these emerging innovators through market structure reform.

This one-size-fits-all approach to regulation is just the type of barrier to economic growth that we need to be tearing down.

We need maximum transparency to ensure it beyond any doubt. The CFPB must do more in this regard.

Just because a government agency has good intentions or a benevolent-sounding name doesn't mean Congress should just look the other way while tens of millions of Americans are having their financial history gathered up and stored.

I strongly support the Consumer Financial Protection Bureau and think they have been doing an excellent job on behalf of the consumers.

I am currently working on legislation that will require our Federal agencies to consider alternatives to expensive travel

the taxpayers deserve, especially when an agency is given a very unique ability to spend the public's money without congressional approval